查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1826802

2025年肝病診斷全球市場報告

Liver Disease Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，肝病診斷市場規模強勁成長，從2024年的362.6億美元增加至2025年的389.5億美元，複合年成長率為7.4%。預測期內的成長可歸因於急性和慢性肝病盛行率的上升、肝病盛行率的上升、酒精消費量的增加、人們對肝臟健康的認知的提高以及醫療基礎設施的不斷擴展。

預計未來幾年肝病診斷市場將強勁成長，2029年將達到516.2億美元，複合年成長率為7.3%。預測期內成長的主要促進因素包括老年人口的成長、研發支出的增加、切片檢查程序和疾病的增加以及遠端醫療的普及。預測期內的主要趨勢包括個人化醫療的興起、診斷套件的技術進步、快速檢測的進步、醫療保健的技術進步以及診斷方法的技術進步。

肝病診斷包括用於檢測和評估各種肝病（包括肝硬化、肝炎、脂肪肝和肝癌）的醫療程序和檢查。這些診斷程序通常包括：血液檢查（用於測量肝臟酵素水平）、影像學檢查（例如超音波或CT掃描），有時還包括切片檢查（用於取出組織樣本）。

肝病的主要診斷方法包括實驗室檢查、影像學檢查、內視鏡檢查和切片檢查。實驗室檢查透過分析血液和其他樣本來確定肝臟狀況。這些檢查用於診斷非酒精性脂肪肝病、非酒精性脂肪性肝炎、纖維化、肝硬化和肝細胞癌等疾病。這些檢查的最終使用者包括醫院、實驗室和其他醫療機構。

2025 年春季美國突然提高關稅以及由此引發的貿易摩擦對醫療保健產業產生了重大影響，尤其是基本醫療設備、診斷設備和藥品的供應。醫院和醫療保健提供者正努力應對進口手術器械、診斷影像系統以及注射器和導管等消耗品成本的上漲，其中許多產品的國內替代品有限。這些不斷上漲的成本使醫療保健預算捉襟見肘，導致一些醫療機構推遲設備升級或將增加的費用轉嫁給患者。此外，原料和零件的關稅擾亂了關鍵藥品和醫療設備的生產，造成供應鏈延遲。作為應對措施，該行業正在採用多樣化的籌資策略，盡可能擴大本地生產，並遊說對關鍵醫療產品免關稅。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供肝病診斷市場統計數據，包括全球市場規模、區域佔有率、肝病診斷市場佔有率競爭對手、詳細的肝病診斷細分市場、市場趨勢和機遇，以及您在肝病診斷行業取得成功所需的數據。本肝病診斷市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年7.3%的成長預測比我們先前的預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。關稅上漲可能會增加美國實驗室的負擔，因為這會增加從中國和荷蘭進口的專業肝功能檢測試劑盒和FibroScan設備的成本，從而加劇診斷延誤，並增加肝病檢測的成本。互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響可能會產生更廣泛的影響。

預計酒精消費量的上升將推動肝病診斷市場的成長。由於社會規範的改變、價格承受能力的提高、酒精的廣泛供應以及壓力和心理健康挑戰的增加，酒精消費量正在增加。由於飲酒會影響肝臟健康，因此診斷工具對於早期發現脂肪肝、肝炎和肝硬化等肝損傷徵兆至關重要。例如，根據英國國家醫療服務體系 (NHS) 2022 年 12 月的數據，酒精消費量隨著年齡的成長而增加，62% 的 16 至 24 歲人群報告在過去 12 個月內飲酒，85% 的 55 至 74 歲人群飲酒。這一趨勢正在推動肝病診斷市場的成長，因為人們對早期發現和監測肝臟健康的需求日益成長。

肝病診斷市場的公司正專注於開發創新的、非侵入性工具來評估肝臟健康狀況。這些工具提供了準確有效的診斷方法，而無需切片檢查等侵入性程序。例如，2024 年 9 月，印度診斷中心 City Imaging & Clinical 推出了 FibroScan，這是一種非侵入性診斷工具，旨在早期發現肝病，例如非酒精性脂肪肝病 (NAFLD) 和酒精性肝病 (ALD)。 FibroScan 使用彈性成像技術快速且準確地測量肝臟硬度和脂肪含量，為傳統切片檢查提供了一種非侵入性替代方案。該過程僅需 5 到 15 分鐘；將探針放在肝臟上並發出聲波以評估肝組織硬度，從而能夠早期診斷纖維化和疤痕形成等疾病。

2024年8月，美國醫療檢測公司Quest Diagnostics以10億美元收購了LifeLabs。此次收購預計將顯著增強Quest Diagnostics的營運能力，並拓展其在加拿大的醫療服務。總部位於加拿大的LifeLabs專注於肝病診斷，尤其擅長非酒精性脂肪性肝病（NAFLD）等疾病的診斷，此次收購將拓寬Quest在該領域的診斷服務。

肝病診斷市場由提供肝病診斷、影像檢查、纖維化評估、病毒性肝炎篩檢和酒精相關肝病評估等服務的提供者所獲得的收益所構成。市場價值包括服務提供者銷售的或包含在其服務產品中的相關產品的價值。肝病診斷市場還包括血液檢測套組、診斷影像設備以及切片穿刺針和器械的銷售。此市場的價值是指“出廠價”，即產品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場中的產品價值還包括產品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球肝病診斷：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球肝病診斷市場：成長率分析
  • 全球肝病診斷市場表現：規模與成長，2019-2024
  • 全球肝病診斷市場預測：規模與成長，2024-2029年，2034年
  • 全球肝病診斷：總目標市場（TAM）

第6章 市場細分

  • 全球肝病診斷市場（依診斷技術）：2019-2024 年、2024-2029 年、2034 年表現與預測
  • 實驗室檢查
  • 影像學
  • 內視鏡檢查
  • 切片檢查
  • 其他診斷技術
  • 全球肝病診斷市場：按疾病、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 非酒精性脂肪肝
  • 非酒精性脂肪性肝炎
  • 纖維化
  • 肝硬化
  • 肝細胞癌
  • 其他疾病
  • 全球肝病診斷市場（按最終用戶、績效和預測）2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 研究所
  • 其他最終用戶
  • 全球肝病診斷市場：按臨床測試類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 血液檢查（肝功能檢查、肝炎檢查）
  • 酵素測試（ALT、AST、ALP）
  • 基因檢測
  • 血清檢測
  • 全球肝病診斷市場：依影像（類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 超音波影像
  • 電腦斷層掃描
  • MRI
  • 彈性成像（FibroScan）
  • 全球肝病診斷市場：內視鏡細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 食道胃十二指腸鏡檢查（EGD）
  • 膠囊內視鏡
  • 全球肝病診斷市場：依切片檢查類型、表現及預測細分，2019-2024 年、2024-2029 年、2034 年
  • 切片檢查（針吸切片）
  • 細針穿刺切片檢查
  • 腹腔鏡切片檢查
  • 全球肝病診斷市場：依其他診斷技術細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 分子影像
  • 生物標記檢測
  • 纖維化評分系統

第7章 區域和國家分析

  • 全球肝病診斷市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球肝病診斷市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 肝病診斷市場：競爭格局
  • 肝病診斷市場：公司簡介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Echosens SA Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Boston Scientific Corporation
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Siemens Healthineers AG
  • bioMerieux SA
  • Genentech Inc.
  • Perspectum Diagnostics Ltd.
  • Owlstone Medical Ltd.
  • Enterome SA
  • Atlentis Therapeutics AG
  • 89bio Inc.
  • Aligos Therapeutics Inc.
  • BioPredictive SAS
  • Cosara Diagnostics Pvt. Ltd.
  • Hepion Pharmaceuticals Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年肝病診斷市場：提供新機會的國家
  • 2029 年肝病診斷市場：細分市場將帶來新機會
  • 2029年肝病診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r33792u

Liver disease diagnostics encompass the medical procedures and tests used to detect and evaluate a range of liver conditions, such as liver cirrhosis, hepatitis, fatty liver disease, and liver cancer. These diagnostic methods typically include blood tests to measure liver enzyme levels, imaging techniques such as ultrasound or CT scans, and occasionally biopsy procedures to collect tissue samples.

The primary diagnostic techniques for liver disease include laboratory tests, imaging, endoscopy, biopsy, and other methods. Laboratory tests involve analyzing blood and other samples to identify liver conditions. These tests are used to diagnose diseases such as non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, fibrosis, cirrhosis, hepatocellular carcinoma, and more. They are utilized by a variety of end users, including hospitals, laboratories, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The liver disease diagnostics market research report is one of a series of new reports from The Business Research Company that provides liver disease diagnostics market statistics, including liver disease diagnostics industry global market size, regional shares, competitors with a liver disease diagnostics market share, detailed liver disease diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the liver disease diagnostics industry. This liver disease diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The liver disease diagnostics market size has grown strongly in recent years. It will grow from $36.26 billion in 2024 to $38.95 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to the growing prevalence of both acute and chronic liver conditions, increasing prevalence of liver diseases, increasing consumption of alcohol, rising awareness towards liver health, and expanding healthcare infrastructure.

The liver disease diagnostics market size is expected to see strong growth in the next few years. It will grow to $51.62 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to an increase in the geriatric population, rising research & development spending, an increasing number of biopsy procedures and diseases, and expanding telemedicine adoption. Major trends in the forecast period include the rise of personalized medicine, technological advancements in diagnostic kits, advancements in rapid tests, technological advancement in the healthcare sector, and technological advancements in diagnostic methods.

The forecast of 7.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. laboratories by driving up the cost of specialized liver function test panels and FibroScan equipment sourced from China and the Netherlands, exacerbating diagnostic delays and increasing hepatology workup expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rise in alcohol consumption is expected to drive the growth of the liver disease diagnostics market. Alcohol consumption has increased due to changing social norms, greater affordability, widespread availability, and rising stress or mental health challenges. As alcohol consumption impacts liver health, diagnostic tools are essential for detecting early signs of liver damage, such as fatty liver, hepatitis, or cirrhosis. For example, according to the National Health Service (NHS) in December 2022, alcohol consumption rose with age, with 62% of individuals aged 16 to 24 reporting consumption in the past 12 months, and 85% of individuals aged 55 to 74 engaging in alcohol consumption. This trend is contributing to the growth of the liver disease diagnostics market, as there is a greater need for early detection and monitoring of liver health.

Companies in the liver disease diagnostics market are focusing on the development of innovative, non-invasive tools to assess liver conditions. These tools provide accurate and efficient diagnostic methods without the need for invasive procedures such as biopsies. For instance, in September 2024, City Imaging & Clinical, an India-based diagnostic center, launched FibroScan, a non-invasive diagnostic tool aimed at the early detection of liver diseases such as non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). FibroScan uses elastography technology to measure liver stiffness and fat content quickly and accurately, offering a non-invasive alternative to traditional biopsies. The procedure takes only 5 to 15 minutes and involves placing a probe over the liver, which emits sound waves to assess liver tissue stiffness, enabling early diagnosis of conditions such as fibrosis or scarring.

In August 2024, Quest Diagnostics, a US-based medical laboratory company, acquired LifeLabs for $1 billion. This acquisition is expected to significantly enhance Quest Diagnostics' operational capabilities and expand its healthcare services in Canada. LifeLabs, a Canada-based laboratory company, specializes in liver disease diagnostics, particularly focusing on conditions such as non-alcoholic fatty liver disease (NAFLD), and the acquisition will help broaden Quest's diagnostic offerings in this area.

Major players in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Echosens SA, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG, bioMerieux SA, Genentech Inc., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., Enterome SA, Atlentis Therapeutics AG, 89bio Inc., Aligos Therapeutics Inc., BioPredictive SAS, Cosara Diagnostics Pvt. Ltd., Hepion Pharmaceuticals Inc., HEPQuant LLC, and Aiforia Technologies Plc.

North America was the largest region in the liver disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in liver disease diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the liver disease diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The liver disease diagnostics market consists of revenues earned by entities by providing services such as liver disease diagnostics, imaging studies, fibrosis assessment, viral hepatitis screening, and alcohol-related liver disease evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. The liver disease diagnostics market also includes sales of blood test kits, imaging devices, and biopsy needles and instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Liver Disease Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on liver disease diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for liver disease diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The liver disease diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Diagnosis Technique: Laboratory Tests; Imaging; Endoscopy; Biopsy; Other Diagnosis Techniques
  • 2) By Disease: Non-Alcoholic Fatty Liver Disease; Non-Alcoholic Steatohepatitis; Fibrosis; Cirrhosis; Hepatocellular Carcinoma; Other Diseases
  • 3) By End Users: Hospitals; Laboratories; Other End Users
  • Subsegments:
  • 1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel); Enzyme Tests (ALT, AST, ALP); Genetic Testing; Serological Tests
  • 2) By Imaging: Ultrasound Imaging; CT Scans; MRI; Elastography (FibroScan)
  • 3) By Endoscopy: Esophagogastroduodenoscopy (EGD); Capsule Endoscopy
  • 4) By Biopsy: Liver Biopsy (Needle Biopsy); Fine Needle Aspiration Biopsy; Laparoscopic Biopsy
  • 5) By Other Diagnosis Techniques: Molecular Imaging; Biomarker Testing; Fibrosis Scoring Systems
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Thermo Fisher Scientific Inc.; Fujifilm Holdings Corporation; Echosens SA; Boston Scientific Corporation; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Siemens Healthineers AG; bioMerieux SA; Genentech Inc.; Perspectum Diagnostics Ltd.; Owlstone Medical Ltd.; Enterome SA; Atlentis Therapeutics AG; 89bio Inc.; Aligos Therapeutics Inc.; BioPredictive SAS; Cosara Diagnostics Pvt. Ltd.; Hepion Pharmaceuticals Inc.; HEPQuant LLC; Aiforia Technologies Plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Liver Disease Diagnostics Market Characteristics

3. Liver Disease Diagnostics Market Trends And Strategies

4. Liver Disease Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Liver Disease Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Liver Disease Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Liver Disease Diagnostics Market Growth Rate Analysis
  • 5.4. Global Liver Disease Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Liver Disease Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Liver Disease Diagnostics Total Addressable Market (TAM)

6. Liver Disease Diagnostics Market Segmentation

  • 6.1. Global Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Tests
  • Imaging
  • Endoscopy
  • Biopsy
  • Other Diagnosis Techniques
  • 6.2. Global Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Alcoholic Fatty Liver Disease
  • Non-Alcoholic Steatohepatitis
  • Fibrosis
  • Cirrhosis
  • Hepatocellular Carcinoma
  • Other Diseases
  • 6.3. Global Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Laboratories
  • Other End Users
  • 6.4. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Laboratory Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Tests (Liver Function Tests, Hepatitis Panel)
  • Enzyme Tests (ALT, AST, ALP)
  • Genetic Testing
  • Serological Tests
  • 6.5. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Imaging, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ultrasound Imaging
  • CT Scans
  • MRI
  • Elastography (FibroScan)
  • 6.6. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Endoscopy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Esophagogastroduodenoscopy (EGD)
  • Capsule Endoscopy
  • 6.7. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liver Biopsy (Needle Biopsy)
  • Fine Needle Aspiration Biopsy
  • Laparoscopic Biopsy
  • 6.8. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Other Diagnosis Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Imaging
  • Biomarker Testing
  • Fibrosis Scoring Systems

7. Liver Disease Diagnostics Market Regional And Country Analysis

  • 7.1. Global Liver Disease Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Liver Disease Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Liver Disease Diagnostics Market

  • 8.1. Asia-Pacific Liver Disease Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Liver Disease Diagnostics Market

  • 9.1. China Liver Disease Diagnostics Market Overview
  • 9.2. China Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Liver Disease Diagnostics Market

  • 10.1. India Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Liver Disease Diagnostics Market

  • 11.1. Japan Liver Disease Diagnostics Market Overview
  • 11.2. Japan Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Liver Disease Diagnostics Market

  • 12.1. Australia Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Liver Disease Diagnostics Market

  • 13.1. Indonesia Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Liver Disease Diagnostics Market

  • 14.1. South Korea Liver Disease Diagnostics Market Overview
  • 14.2. South Korea Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Liver Disease Diagnostics Market

  • 15.1. Western Europe Liver Disease Diagnostics Market Overview
  • 15.2. Western Europe Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Liver Disease Diagnostics Market

  • 16.1. UK Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Liver Disease Diagnostics Market

  • 17.1. Germany Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Liver Disease Diagnostics Market

  • 18.1. France Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Liver Disease Diagnostics Market

  • 19.1. Italy Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Liver Disease Diagnostics Market

  • 20.1. Spain Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Liver Disease Diagnostics Market

  • 21.1. Eastern Europe Liver Disease Diagnostics Market Overview
  • 21.2. Eastern Europe Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Liver Disease Diagnostics Market

  • 22.1. Russia Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Liver Disease Diagnostics Market

  • 23.1. North America Liver Disease Diagnostics Market Overview
  • 23.2. North America Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Liver Disease Diagnostics Market

  • 24.1. USA Liver Disease Diagnostics Market Overview
  • 24.2. USA Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Liver Disease Diagnostics Market

  • 25.1. Canada Liver Disease Diagnostics Market Overview
  • 25.2. Canada Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Liver Disease Diagnostics Market

  • 26.1. South America Liver Disease Diagnostics Market Overview
  • 26.2. South America Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Liver Disease Diagnostics Market

  • 27.1. Brazil Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Liver Disease Diagnostics Market

  • 28.1. Middle East Liver Disease Diagnostics Market Overview
  • 28.2. Middle East Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Liver Disease Diagnostics Market

  • 29.1. Africa Liver Disease Diagnostics Market Overview
  • 29.2. Africa Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Liver Disease Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Liver Disease Diagnostics Market Competitive Landscape
  • 30.2. Liver Disease Diagnostics Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Echosens SA Overview, Products and Services, Strategy and Financial Analysis

31. Liver Disease Diagnostics Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. Laboratory Corporation of America Holdings
  • 31.3. Quest Diagnostics Incorporated
  • 31.4. Siemens Healthineers AG
  • 31.5. bioMerieux SA
  • 31.6. Genentech Inc.
  • 31.7. Perspectum Diagnostics Ltd.
  • 31.8. Owlstone Medical Ltd.
  • 31.9. Enterome SA
  • 31.10. Atlentis Therapeutics AG
  • 31.11. 89bio Inc.
  • 31.12. Aligos Therapeutics Inc.
  • 31.13. BioPredictive SAS
  • 31.14. Cosara Diagnostics Pvt. Ltd.
  • 31.15. Hepion Pharmaceuticals Inc.

32. Global Liver Disease Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Liver Disease Diagnostics Market

34. Recent Developments In The Liver Disease Diagnostics Market

35. Liver Disease Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Liver Disease Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Liver Disease Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Liver Disease Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer